Skip to Content

Press Release

Exercise of Options & Issue of Equity

June 20, 2014 at 7:00 AM BST

Released : Jun 20, 2014

20 June 2014



Tiziana Life Sciences plc (AIM: TILS) (the "Company"), a UK biotechnology company with a focus on therapeutic and diagnostic applications for cancer, announces that the Company has received a notification from option holders to exercise options over 84,666 ordinary shares in the Company at an exercise price of 3p per share, providing the Company with gross proceeds of £2,540.

Application will be made to the London Stock Exchange to admit the 84,666 new ordinary shares to trading on AIM.  Admission of the new ordinary shares is expected to occur on or around 26 June 2014.  The new ordinary shares will rank pari passu with the existing ordinary shares.

Following the issue of shares detailed above the so enlarged issued share capital of the Company will comprise of 84,640,979 ordinary shares of 3p each.


Tiziana Life Sciences PLC
Philip Boyd
+44 (0)20 7493 2853
Cairn Financial Advisers LLP - Nominated Adviser
Liam Murray / Avi Robinson
+44 (0)20 7148 7900
Beaufort Securities Limited - Broker
Saif Janjua
+44 (0)20 7382 8300
FTI Consulting Limited
John Dineen
+44 (0)20 3727 1136

About Tiziana Life Sciences
Tiziana Life Sciences is a UK biotechnology company whose mission is to discover and develop novel molecules that impact human disease in the area of oncology, with a particular focus on metastatic cancers.

For more information go to



This announcement is distributed by NASDAQ OMX Corporate Solutions on behalf of NASDAQ OMX Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Tiziana Life Sciences PLC via Globenewswire